$9.80
-0.0607-0.62%
Ult. Agg.: Oct 22, 7:56 PM
$9.80
-0.0607-0.62%
Kura Oncology (KURA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.88 | $-0.80 | $-0.58 | $-0.63 |
| Actual | $-0.77 | $-0.83 | $-0.92 | $-0.85 |
| Surprise | +12.5% | -3.75% | -58.6% | -34.9% |
| Revenue | ||||
| Estimate | $19.5M | $23.7M | $33.2M | $62.0M |
| Actual | $20.9M | $18.3M | $17.3M | $20.8M |
| Surprise | +6.93% | -23.1% | -47.8% | -66.5% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.81 | $-0.80 | $-0.63 | $-0.62 |
| Revenue | ||||
| Consensus | $23.5M | $35.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.77 | $-0.88 | 12.5 % |
| Q1 | May 12, 2026 | $-0.83 | $-0.80 | -3.75 % |
| Q4 | Mar 5, 2026 | $-0.92 | $-0.58 | -58.6 % |
| Q3 | Nov 4, 2025 | $-0.85 | $-0.63 | -34.9 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $20.87M | $19.52M | 6.93 % |
| Q1 | May 12, 2026 | $18.27M | $23.75M | -23.1 % |
| Q4 | Mar 5, 2026 | $17.34M | $33.20M | -47.8 % |
| Q3 | Nov 4, 2025 | $20.75M | $61.98M | -66.5 % |